ACILGUANIDINAS

COMPUESTOS DE GUANIDINA DE FORMULA III, TENIENDO X(2) LOS SIGNIFICADOS INDICADOS EN LAS REIVINDICACIONES. SE UTILIZAN EN LA PREPARACION DE MEDICAMENTOS VALIOSOS ANTIARRITMICOS CON COMPONENTES CARDIOPROTECTORES PARA LA PREVENCION DEL INFARTO Y PARA EL TRATAMIENTO DEL INFARTO, ASI COMO PARA EL TRATAMI...

Full description

Saved in:
Bibliographic Details
Main Authors KLEEMANN, HEINZ-WERNER DR, LANG, HANS-JOCHEN DR, ALBUS, UDO DR, WEICHERT, ANDREAS DR, CRAUSE, PETER DR, SCHOLZ, WOLFGANG DR
Format Patent
LanguageSpanish
Published 01.07.2004
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
Abstract COMPUESTOS DE GUANIDINA DE FORMULA III, TENIENDO X(2) LOS SIGNIFICADOS INDICADOS EN LAS REIVINDICACIONES. SE UTILIZAN EN LA PREPARACION DE MEDICAMENTOS VALIOSOS ANTIARRITMICOS CON COMPONENTES CARDIOPROTECTORES PARA LA PREVENCION DEL INFARTO Y PARA EL TRATAMIENTO DEL INFARTO, ASI COMO PARA EL TRATAMIENTO DE LA ANGINA PECTORAL, DADO QUE ELLOS DE MANERA PREVENTIVA INHIBEN O BAJAN MUCHO LOS PROCESOS PATOFISIOLOGICOS CON LA APARICION DE LESIONES INDUCIDAS ISQUEMICAMENTE, EN PARTICULAR LA DESCARGA DE ARRITMIAS CARDIACAS INDUCIDAS ISQUEMICAMENTE. A CAUSA DE SUS EFECTOS PROTECTORES CONTRA SITUACIONES PATOLOGICAS DE HIPOXIA Y DE ISQUEMIA SE PUEDEN UTILIZAR ESTOS COMPUESTOS A CAUSA DE SU INHIBICION DEL MECANISMO DE INTERCAMBIO CELULAR NA + /H + COMO MEDICAMENTO PARA EL TRATAMIENTO DE TODAS LAS LES IONES AGUDAS O CRONICAS ORIGINADAS POR ISQUEMIA, O ENFERMEDADES INDUCIDAS DE MANERA PRIMARIA O SECUNDARIA. Benzoyl-guanidine derivatives (III) are new. (III) are of formula X2-CO-N=C(NH2)2 X2 = R101 = hydrogen, fluoro, chloro, hydroxy, amino or trifluoromethyl; R102 = hydrogen, fluoro, chloro, bromo, cyano, CqF2qCF3, R13SO2, R14R15NCO, R16CO or R17R18NSO2; R13, R14, R16 and R17 = 1-8C alkyl, 3-4C alkenyl, CnH2n-R20, trifluoromethyl or, except for R13, hydrogen; n = 0 or 1; q = 1-5; R20 = 3-6C cycloalkyl or phenyl, optionally substituted by 1-2 of fluoro, chloro, trifluoromethyl, methyl, methoxy or NR21R22; R21 and R22 = hydrogen or methyl; R104 = 1-8C alkyl, CnH2nR20, trifluoromethyl, (iso)quinolyl, pyrrolyl, pyridyl or imidazolyl (all these rings bonded via carbon or nitrogen and optionally substituted by 1 or 2 fluoro, chloro, trifluoromethyl, methoxy, hydroxy or amino (optionally substituted by 1 or 2 methyl)), R87SO2, R88R89NSO2, or R93-ethynyl; R87 = 1-4C alkyl or trifluoromethyl; R88 = hydrogen, 1-4C alkyl, trifluoromethyl, or (CH2)anR90; an = 0 or 1; R90 and R93 = phenyl, optionally substituted as in R20; R103 = any of a wide range of substituents . The full definitions are given in the DEFINITIONS (Full Definitions) Field.
AbstractList COMPUESTOS DE GUANIDINA DE FORMULA III, TENIENDO X(2) LOS SIGNIFICADOS INDICADOS EN LAS REIVINDICACIONES. SE UTILIZAN EN LA PREPARACION DE MEDICAMENTOS VALIOSOS ANTIARRITMICOS CON COMPONENTES CARDIOPROTECTORES PARA LA PREVENCION DEL INFARTO Y PARA EL TRATAMIENTO DEL INFARTO, ASI COMO PARA EL TRATAMIENTO DE LA ANGINA PECTORAL, DADO QUE ELLOS DE MANERA PREVENTIVA INHIBEN O BAJAN MUCHO LOS PROCESOS PATOFISIOLOGICOS CON LA APARICION DE LESIONES INDUCIDAS ISQUEMICAMENTE, EN PARTICULAR LA DESCARGA DE ARRITMIAS CARDIACAS INDUCIDAS ISQUEMICAMENTE. A CAUSA DE SUS EFECTOS PROTECTORES CONTRA SITUACIONES PATOLOGICAS DE HIPOXIA Y DE ISQUEMIA SE PUEDEN UTILIZAR ESTOS COMPUESTOS A CAUSA DE SU INHIBICION DEL MECANISMO DE INTERCAMBIO CELULAR NA + /H + COMO MEDICAMENTO PARA EL TRATAMIENTO DE TODAS LAS LES IONES AGUDAS O CRONICAS ORIGINADAS POR ISQUEMIA, O ENFERMEDADES INDUCIDAS DE MANERA PRIMARIA O SECUNDARIA. Benzoyl-guanidine derivatives (III) are new. (III) are of formula X2-CO-N=C(NH2)2 X2 = R101 = hydrogen, fluoro, chloro, hydroxy, amino or trifluoromethyl; R102 = hydrogen, fluoro, chloro, bromo, cyano, CqF2qCF3, R13SO2, R14R15NCO, R16CO or R17R18NSO2; R13, R14, R16 and R17 = 1-8C alkyl, 3-4C alkenyl, CnH2n-R20, trifluoromethyl or, except for R13, hydrogen; n = 0 or 1; q = 1-5; R20 = 3-6C cycloalkyl or phenyl, optionally substituted by 1-2 of fluoro, chloro, trifluoromethyl, methyl, methoxy or NR21R22; R21 and R22 = hydrogen or methyl; R104 = 1-8C alkyl, CnH2nR20, trifluoromethyl, (iso)quinolyl, pyrrolyl, pyridyl or imidazolyl (all these rings bonded via carbon or nitrogen and optionally substituted by 1 or 2 fluoro, chloro, trifluoromethyl, methoxy, hydroxy or amino (optionally substituted by 1 or 2 methyl)), R87SO2, R88R89NSO2, or R93-ethynyl; R87 = 1-4C alkyl or trifluoromethyl; R88 = hydrogen, 1-4C alkyl, trifluoromethyl, or (CH2)anR90; an = 0 or 1; R90 and R93 = phenyl, optionally substituted as in R20; R103 = any of a wide range of substituents . The full definitions are given in the DEFINITIONS (Full Definitions) Field.
Author SCHOLZ, WOLFGANG DR
ALBUS, UDO DR
KLEEMANN, HEINZ-WERNER DR
LANG, HANS-JOCHEN DR
WEICHERT, ANDREAS DR
CRAUSE, PETER DR
Author_xml – fullname: KLEEMANN, HEINZ-WERNER DR
– fullname: LANG, HANS-JOCHEN DR
– fullname: ALBUS, UDO DR
– fullname: WEICHERT, ANDREAS DR
– fullname: CRAUSE, PETER DR
– fullname: SCHOLZ, WOLFGANG DR
BookMark eNrjYmDJy89L5WTgc3T29HEPdfTzdPH0cwzmYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxrsFGRoYGFuZGISHGxsSoAQCOZh8d
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Edition 7
ExternalDocumentID ES2210872TT3
GroupedDBID EVB
ID FETCH-epo_espacenet_ES2210872TT33
IEDL.DBID EVB
IngestDate Fri Jul 19 14:20:21 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Spanish
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_ES2210872TT33
Notes Application Number: ES19990102583T
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20040701&DB=EPODOC&CC=ES&NR=2210872T3
ParticipantIDs epo_espacenet_ES2210872TT3
PublicationCentury 2000
PublicationDate 20040701
PublicationDateYYYYMMDD 2004-07-01
PublicationDate_xml – month: 07
  year: 2004
  text: 20040701
  day: 01
PublicationDecade 2000
PublicationYear 2004
RelatedCompanies AVENTIS PHARMA DEUTSCHLAND GMBH
RelatedCompanies_xml – name: AVENTIS PHARMA DEUTSCHLAND GMBH
Score 2.6022112
Snippet COMPUESTOS DE GUANIDINA DE FORMULA III, TENIENDO X(2) LOS SIGNIFICADOS INDICADOS EN LAS REIVINDICACIONES. SE UTILIZAN EN LA PREPARACION DE MEDICAMENTOS...
SourceID epo
SourceType Open Access Repository
SubjectTerms ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title ACILGUANIDINAS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20040701&DB=EPODOC&locale=&CC=ES&NR=2210872T3
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSU1KNk9OszTRNUtLTdI1MUpL1bVIS7PUNU01SzRPSTFOSgKvzfH1M_MINfGKMI1gYsiE7YUBnxNaDj4cEZijkoH5vQRcXhcgBrFcwGsri_WTMoFC-fZuIbYuarDeMbB7AuwbuzjZugb4u_g7qzk72wIbVX5BtkbAro2FuVGIMTMDK7AVbQFa_eca5gTalFKAXKO4CTKwBQANyysRYmBKLRZm4HSGXbwmzMDhC53vBjKhWa9YhIHP0dnTxz3U0c_TxdPPMViUQdHNNcTZQxdocDzcE_GuwTAnhBgbizGwADv3qRIMCpamianmQPcYJJonmyQagToUoAPPweeCARs_ppIMUrjNkcInKc3ABVllAlpaKsPAUlJUmioLrEBLkuTAXgcAGVxyLg
link.rule.ids 230,309,786,891,25585,76894
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSU1KNk9OszTRNUtLTdI1MUpL1bVIS7PUNU01SzRPSTFOSgKvzfH1M_MINfGKMI1gYsiE7YUBnxNaDj4cEZijkoH5vQRcXhcgBrFcwGsri_WTMoFC-fZuIbYuarDeMbB7AuwbuzjZugb4u_g7qzk72wIbVX5BtkbAro2FuVGIMTMDK7CFbQk6Zt81zAm0KaUAuUZxE2RgCwAallcixMCUWizMwOkMu3hNmIHDFzrfDWRCs16xCAOfo7Onj3uoo5-ni6efY7Aog6Kba4izhy7Q4Hi4J-Jdg2FOCDE2FmNgAXbuUyUYFCxNE1PNTU0tDBLNk00SjUAdCtCB5-BzwYCNH1NJBinc5kjhk5Rn4PQI8fWJ9_H085Zm4IKsOAEtM5VhYCkpKk2VBVamJUly4GAAAJ5JdSE
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=ACILGUANIDINAS&rft.inventor=KLEEMANN%2C+HEINZ-WERNER+DR&rft.inventor=LANG%2C+HANS-JOCHEN+DR&rft.inventor=ALBUS%2C+UDO+DR&rft.inventor=WEICHERT%2C+ANDREAS+DR&rft.inventor=CRAUSE%2C+PETER+DR&rft.inventor=SCHOLZ%2C+WOLFGANG+DR&rft.date=2004-07-01&rft.externalDBID=T3&rft.externalDocID=ES2210872TT3